SPDR S&P Biotech ETF (XBI) stock is trading at $155.98 per share, up +2.58% today, in line with the broader market — the S&P 500 is +0.52% today. Over the past year it has moved +41.98%, and it is -0.13% over the last month. It sits -8.19% below its 52-week high of $169.89.
Investors in Canada can buy XBI through most brokerages in US dollars; at today's exchange rate one share costs about CA$218.29.
About SPDR S&P Biotech ETF (XBI)
SPDR S&P Biotech ETF is listed on NYSEArca under the ticker XBI and is classified in the Sector sector. This page shows a live ETF quote that refreshes about every minute while the market is open, plus intraday, 1-month, 6-month and 1-year charts.
SPDR S&P Biotech ETF (XBI) is at $155.98 as of Nov 3, 2026, 11:28 AM EST, up $3.93 (+2.58%) from the previous close of $152.05.
Is XBI up or down today?
+
XBI is up +2.58% today, in line with the broader market — the S&P 500 is +0.52% today. Today's range is $152.83 – $156.92.
Why is SPDR S&P Biotech ETF stock up today?
+
Daily moves usually reflect company news (earnings, guidance, analyst rating changes, product or regulatory news), sector rotation and the overall market mood driven by interest rates, inflation data and the Federal Reserve. Today XBI is moving in line with the broader market — the S&P 500 is +0.52% today. Check the company's investor-relations page and recent filings for specific news.
What is the 52-week high and low for XBI?
+
The 52-week range is $106.30 to $169.89. The current price is -8.19% from the 52-week high.
What is XBI price in Canadian dollars?
+
At today's exchange rate, XBI at $155.98 equals about CA$218.29.
Data for information only and may be delayed. AmpXa is not a broker or financial adviser; nothing here is a recommendation to buy or sell. See our disclaimer.